Regeneron Pharmaceuticals
REGN • NASDAQ
Regeneron Pharmaceuticals is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Leonard S. Schleifer, with a market cap of $81.2B.
Market Cap$81.2B
Employees13.5K
CEOLeonard S. Schleifer
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsApr 29, 2026 · In 2 weeksQ1 2026
Financials
Regeneron Pharmaceuticals FAQ
Common questions about Regeneron Pharmaceuticals
Regeneron Pharmaceuticals is scheduled to report earnings for Q1 2026 on April 29, 2026. Analysts estimate revenue of $3.4B.
Regeneron Pharmaceuticals has approximately 13,450 employees.